{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:00:59Z","timestamp":1782824459401,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.nmd.2020.10.010","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T23:40:51Z","timestamp":1604101251000},"page":"949-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review"],"prefix":"10.1016","volume":"30","author":[{"given":"N.","family":"Kruijt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R.","family":"van den Bersselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wijma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Verbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.H.","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Kamsteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kramers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.10.010_bib0001","first-page":"58","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres","year":"2015","journal-title":"Ochsner J"},{"key":"10.1016\/j.nmd.2020.10.010_bib0002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.10.010_bib0003","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2020.10.010_bib0004","first-page":"533","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie","year":"2013","journal-title":"Ochsner J"},{"key":"10.1016\/j.nmd.2020.10.010_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092288","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","volume":"20","author":"Francescangeli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2020.10.010_bib0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6123(06)62006-2","article-title":"Neuroleptic malignant syndrome and serotonin syndrome","volume":"162","author":"Nisijima","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.nmd.2020.10.010_bib0007","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00005053-198105000-00011","article-title":"Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs","volume":"169","author":"Toru","year":"1981","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.nmd.2020.10.010_bib0008","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1192\/bjp.158.6.850","article-title":"Is the predisposition to neuroleptic malignant syndrome genetically transmitted?","volume":"158","author":"Otani","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.nmd.2020.10.010_bib0009","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1399-6576.1989.tb02990.x","article-title":"The association between the neuroleptic malignant syndrome and malignant hyperthermia","volume":"33","author":"Adnet","year":"1989","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.nmd.2020.10.010_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-510X(96)00015-9","article-title":"No association between the neuroleptic malignant syndrome and mutations in the RYR1 gene associated malignant hyperthermia","volume":"143","author":"Miyatake","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2020.10.010_bib0011","first-page":"28","article-title":"A look at genetic linkage between clozapine-induced agranulocytosis, malignant hyperthermia, neuroleptic malignant syndrome, and statin-induced myopathy","volume":"16","author":"Pothen","year":"2019","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.nmd.2020.10.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135496","article-title":"Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?","volume":"10","author":"Sagui","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2020.10.010_bib0013","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.nmd.2020.10.010_bib0014","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2020.10.010_bib0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2020.10.010_bib0016","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neurol.2016.07.018","article-title":"RYR1-related rhabdomyolysis: a common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction","volume":"172","author":"Voermans","year":"2016","journal-title":"Rev Neurol Paris"},{"key":"10.1016\/j.nmd.2020.10.010_bib0017","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1365-2044.2012.07226.x","article-title":"Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene","volume":"67","author":"Russell","year":"2012","journal-title":"Anaesthesia"},{"key":"10.1016\/j.nmd.2020.10.010_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1941875210386491","article-title":"Neuroleptic malignant syndrome: a review for neurohospitalists","volume":"1","author":"Berman","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.nmd.2020.10.010_bib0019","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1744-6163.2010.00292.x","article-title":"Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?","volume":"47","author":"Steele","year":"2011","journal-title":"Perspect Psychiatr Care"},{"key":"10.1016\/j.nmd.2020.10.010_bib0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/acps.12694","article-title":"A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency","volume":"135","author":"Gurrera","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.nmd.2020.10.010_bib0021","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JCP.0000000000000344","article-title":"Serotonin syndrome: analysis of cases registered in the French pharmacovigilance database","volume":"35","author":"Abadie","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.nmd.2020.10.010_bib0022","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/00000539-199308000-00014","article-title":"Malignant hyperthermia: a review of published cases","volume":"77","author":"Strazis","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2020.10.010_bib0023","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2020.10.010_bib0024","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1399-6576.2007.01293.x","article-title":"Male preponderance of patients testing positive for malignant hyperthermia susceptibility","volume":"51","author":"Islander","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.nmd.2020.10.010_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/NDT.S118438","article-title":"Neuroleptic malignant syndrome: an easily overlooked neurologic emergency","volume":"13","author":"Oruch","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.nmd.2020.10.010_bib0026","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/15563650.2011.649092","article-title":"Acute intoxications: differences in management between six Dutch hospitals","volume":"50","author":"Duineveld","year":"2012","journal-title":"Clin Toxicol Phila"},{"key":"10.1016\/j.nmd.2020.10.010_bib0027","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","article-title":"Rhabdomyolysis: an evaluation of 475 hospitalized patients","volume":"84","author":"Melli","year":"2005","journal-title":"Med Baltim"},{"key":"10.1016\/j.nmd.2020.10.010_bib0028","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-019-09209-z","article-title":"The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations","author":"Knuiman","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2020.10.010_bib0029","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.74.3.385","article-title":"Neuroleptic malignant syndrome in Kufs' disease","volume":"74","author":"Reif","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2020.10.010_bib0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12630-017-0865-5","article-title":"Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review","volume":"64","author":"Kraeva","year":"2017","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.nmd.2020.10.010_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.forsciint.2009.10.014","article-title":"Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome","volume":"194","author":"Sato","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.nmd.2020.10.010_bib0032","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-015-0264-3","article-title":"Rhabdomyolysis: a genetic perspective","volume":"10","author":"Scalco","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2020.10.010_bib0033","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","article-title":"Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States","volume":"116","author":"Brandom","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2020.10.010_bib0034","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/ene.13051","article-title":"Dantrolene as a possible prophylactic treatment for RYR1-related rhabdomyolysis","volume":"23","author":"Scalco","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2020.10.010_bib0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/JCP.0b013e3181ee2ae7","article-title":"Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease","volume":"30","author":"Rajapakse","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.nmd.2020.10.010_bib0036","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.psym.2013.05.003","article-title":"A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics","volume":"55","author":"Aggarwal","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nmd.2020.10.010_bib0037","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/0004867414535672","article-title":"Interpretation of recurrent isolated creatine kinase elevation","volume":"48","author":"Mohan","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.nmd.2020.10.010_bib0038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/YCT.0000000000000184","article-title":"Electroconvulsive in a Schizophrenic Patient With Neuroleptic Malignant Syndrome and Rhabdomyolysis","volume":"31","author":"San Gabriel","year":"2015","journal-title":"J ect"},{"key":"10.1016\/j.nmd.2020.10.010_bib0039","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/WNF.0b013e3181acc92d","article-title":"Neuroleptic malignant syndrome or a statin drug reaction? A case report","volume":"32","author":"Cooper","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.nmd.2020.10.010_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2044.1987.tb02944.x","article-title":"The neuroleptic malignant syndrome. Case report with a review of the literature","volume":"42","author":"Allsop","year":"1987","journal-title":"Anaesthesia"},{"key":"10.1016\/j.nmd.2020.10.010_bib0041","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/jnnp.52.8.1006","article-title":"Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology","volume":"52","author":"Jones","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620306568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620306568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:59Z","timestamp":1760774999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620306568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0960896620306568"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.10.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}